Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine

Participants who had received three doses of BNT162b2 vaccine received either a fourth dose or a bivalent vaccine containing BA.4–BA.5 mRNA; the latter group had higher neutralization against omicron variants.

Saved in:

Bibliographic Details
Published in:	The New England journal of medicine Vol. 388; no. 9; pp. 854 - 857
Main Authors:	Zou, Jing, Kurhade, Chaitanya, Patel, Sohil, Kitchin, Nicholas, Tompkins, Kristin, Cutler, Mark, Cooper, David, Yang, Qi, Cai, Hui, Muik, Alexander, Zhang, Ying, Lee, Dung-Yang, Şahin, Ugur, Anderson, Annaliesa S., Gruber, William C., Xie, Xuping, Swanson, Kena A., Shi, Pei-Yong
Format:	Journal Article
Language:	English
Published:	United States Massachusetts Medical Society 02.03.2023
Subjects:	Antibodies Antibodies, Neutralizing - immunology Antibodies, Viral - immunology Confidence intervals Coronavirus Coronaviruses Correspondence COVID-19 - immunology COVID-19 - therapy COVID-19 - virology COVID-19 Vaccines - immunology COVID-19 Vaccines - therapeutic use Humans Infections Infectious Disease mRNA SARS-CoV-2 - immunology Severe acute respiratory syndrome coronavirus 2 Vaccines Vaccines, Combined - immunology Vaccines, Combined - therapeutic use Viral Infections Viruses United States > US
ISSN:	0028-4793, 1533-4406, 1533-4406
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!